Megakaryopoiesis and myelofibrosis in chronic myeloid leukemia after allogeneic bone marrow transplantation: an immunohistochemical study of 127 patients.
An immunohistochemical and morphometric study was performed on 363 trephine biopsies of the bone marrow derived from 127 patients with chronic myeloid leukemia at standardized end points before and after allogeneic bone marrow transplantation (BMT). The purpose of this investigation was to evaluate features of CD61+ megakaryopoiesis related to successful engraftment. Further, we tried to elucidate possible associations of this lineage, including precursor cells, with the platelet count and reticulin fibrosis during the pretransplant and, specifically, post-transplant periods. A significant correlation was recognizable between the quantity of CD61+ megakaryocytes and the platelet values before BMT and also after completed hematopoietic recovery. In the very early post-transplant period, which is associated with severe thrombocytopenia, patchy regeneration of disarranged hematopoiesis occurred, including dysplastic megakaryocytes. According to planimetric measurements after BMT, the atypical micromegakaryocytes characteristic for chronic myeloid leukemia disappeared, and the engrafted donor bone marrow revealed a prevalence of normal-size cells of this lineage. On the other hand, normalization of megakaryocyte size was absent in sequential examinations of the few patients with a leukemic relapse who had a predominance of atypical dwarf forms comparable with chronic myeloid leukemia. Before BMT occurred, reticulin fiber density was significantly correlated with the number of CD61+ megakaryocytes and its precursor cell population. In 34 patients with myelofibrosis that occurred after myelo-ablative therapy and BMT, an initial regression was followed by an insidious recurrence of fibers concentrated in the areas of regenerating hematopoiesis. This postgraft reappearance of reticulin fibrosis was significantly associated with the quantity of megakaryocytes. Regarding engraftment parameters, pretransplant presence of (reticulin) myelofibrosis exerted a distinctive impact because of a delayed hematopoietic reconstitution according to standard clinical criteria. In line with this finding, slowed engraftment was also significantly related with higher pretransplant megakaryocyte and platelet counts.
Thiele
J
J
Institutes of Pathology, Universities of Cologne, Cologne, Germany.
Kvasnicka
H M
HM
Beelen
D W
DW
Flucke
U
U
Spoer
C
C
Paperno
S
S
Leder
L D
LD
Schaefer
U W
UW
D000328:Adult; D015703:Antigens, CD / Q000032:analysis; D001853:Bone Marrow / Q000737:chemistry / Q000473:pathology* / Q000502:physiology; D016026:Bone Marrow Transplantation; D002452:Cell Count; D005260:Female; D006410:Hematopoiesis; D006801:Humans; D007150:Immunohistochemistry; D039661:Integrin beta3; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000473:pathology* / Q000628:therapy; D008297:Male; D008533:Megakaryocytes / Q000737:chemistry / Q000473:pathology*; D010980:Platelet Membrane Glycoproteins / Q000032:analysis; D055728:Primary Myelofibrosis / Q000209:etiology / Q000473:pathology* / Q000503:physiopathology; D012189:Retrospective Studies; D014184:Transplantation, Homologous
D015703:Antigens, CD; D039661:Integrin beta3; D010980:Platelet Membrane Glycoproteins